Scentech Medical is one of the world’s leading companies mapping and commercializing VOC’s (volatile organic compounds) based biomarkers.
The company specializes in developing advanced medical diagnostic systems for detecting broad range of diseases.
Our Mission: To save lives by developing early detection systems for pathogens and cancers.
Our Vision: To be a global leader providing medical diagnostic and biological security solutions.
Scentech Medical is transforming the field of medical diagnostics by providing non-invasive, rapid tests that extend beyond typical clinical applications.
Scentech Medical, is currently in the process of merging with NextGen BioMed (TASE:NXGN), a public company listed on the Tel Avi Stock Exchange (TASE) in Israel.
